Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, October 15, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Enveda Raises $311 Million to Advance AI-Discovered Drug Pipeline
Life Sciences Times
-
September 23, 2026
Venture Capital
Biolevate Raises €30 Million ($34.4 Million) Series A, Opens Boston Office
Life Sciences Times
-
September 22, 2026
Biotech
Sling Therapeutics Raises $123 Million to Advance Linsitinib for Thyroid Eye Disease
Life Sciences Times
-
September 16, 2026
0
Venture Capital
Nix Biosensors Raises $10 Million Series A to Expand Hydration Technology
Life Sciences Times
-
September 15, 2026
0
Venture Capital
Frazier Life Sciences Adds More Than $1.1 Billion to Public Fund
Life Sciences Times
-
September 10, 2026
0
Biotech
Superluminal Medicines Raises $60 Million to Advance Obesity Drug Program
Life Sciences Times
-
September 3, 2026
0
Venture Capital
Elucid Raises $55 Million to Expand AI-Powered Cardiovascular Imaging Platform
Life Sciences Times
-
September 2, 2026
0
Biotech
Abcuro Raises $66 Million to Advance Ulviprubart in Inclusion Body Myositis
Life Sciences Times
-
August 18, 2026
0
Venture Capital
InduPro Raises $77 Million, Doses First Patient in Phase 1 Trial of Lead Cancer Therapy
Life Sciences Times
-
August 12, 2026
0
Biotech
Expedition Therapeutics Raises $115 Million, Begins Phase 2 COPD Trial
Life Sciences Times
-
August 5, 2026
0
Pharma
Apnimed Prices Upsized IPO at $16 Per Share, Raising $192 Million
Life Sciences Times
-
August 3, 2026
0
Venture Capital
Dash Bio Raises $30 Million Series A to Speed Drug Development
Life Sciences Times
-
August 3, 2026
0
Biotech
Adjuvia Therapeutics Raises $8 Million to Advance Mitochondrial Disease Drug
Life Sciences Times
-
July 29, 2026
0
Biotech
CORE Biomedicine Raises $21 Million to Advance Precision Cancer Therapies
Life Sciences Times
-
July 28, 2026
0
1
2
3
...
115
Page 1 of 115
Most Read
Verastem Oncology Names Michael Bailey CEO as Daniel Paterson Plans Retirement
October 14, 2026
Zai Lab to Present First Human Trial Data for Experimental Atopic Dermatitis Treatment
October 14, 2026
Takeda Reports Positive Phase 2/3 Results for Experimental Immunodeficiency Treatment
October 14, 2026
Akamis Bio Completes Enrollment in Phase 1b Rectal Cancer Treatment Study
October 14, 2026